Applied dna regains compliance with nasdaq minimum bid price requirement

Stony brook, ny / accesswire / may 10, 2024 / applied dna sciences, inc. (nasdaq:apdn) (applied dna), a leader in pcr-based dna technologies, today announced that on may 9, 2024, it received a notification letter (the "notification letter") from the listing qualifications department of the nasdaq stock market ("nasdaq"), informing the company that it has regained compliance with the minimum bid price requirement set forth in nasdaq listing rule 5550(a)(2) (the "minimum bid price requirement"). as previously reported, the company was notified on december 1, 2023, that its ordinary shares failed to maintain a minimum bid price of $1.00 over the previous 30 consecutive business days as required by the minimum bid price requirement.
APDN Ratings Summary
APDN Quant Ranking